Prolaris
Payments companies reported to CMS as associated with Prolaris. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Prolaris, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Prolaris
These are the largest totals companies reported as associated with Prolaris. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Adam Cole | Little Rock, AR | Anatomic Pathology & Clinical Pathology | $53,472.01 |
| Christopher Lee | Spokane Valley, WA | Radiation Oncology | $44,739.54 |
| Angelo Baccala | Allentown, PA | Urology | $38,315.75 |
| Jonathan Tward | Salt Lake City, UT | Radiation Oncology | $18,898.07 |
| Todd Cohen | Charlotte, NC | Urology | $17,600.00 |
| Jason Hafron | West Bloomfield, MI | Urology | $9,468.26 |
| Kirk Wojno | Royal Oak, MI | Anatomic Pathology & Clinical Pathology | $6,956.84 |
| Jonathan Hamilton | Greenville, NC | Urology | $6,267.96 |
| Mark Edney | Berlin, MD | Urology | $4,634.60 |
| Paul Sieber | Lancaster, PA | Urology | $4,288.55 |
Prescribed Prolaris?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.